Adtec Healthcare Limited celebrates today

We’re excited today to celebrate the establishment of Adtec Healthcare Limited as a separate entity from Adtec Europe Ltd. Adtec Healthcare Limited, originally part of the European subsidiary of its parent company Adtec Plasma Technology Japan, was the first company worldwide to introduce Cold Plasma on wounds in clinical trials. Adtec Healthcare offers its thanks and praises to Adtec Plasma Technology Japan for its continued financial support and guidance which without whom we would not be the leading Cold Plasma company we are today.

 

What does this mean for us?

 

Now officially exclusively operating as a Healthcare company, we can speak with investors and wound care companies to introduce our patented technology and collaborate to accelerate sales in Europe as well as launching the technology in the USA where a strong interest for Adtec Healthcare’s Cold Plasma from clinicians has already been established. The new investment will be used towards clinical studies and gaining FDA approval.

 

What does this mean for you?

 

Adtec Healthcare Limited will continue to operate from its office in London and our working relationships with distributors and customers will continue as normal. Our company’s footprint is set to expand, and we will be in touch in the coming months to update you of our progress.

 

The experienced Adtec Healthcare Limited team, led by Mary McGovern, are excited to start this next chapter on their mission to revolutionize the global wound care market working alongside financial and strategic partners.

 

https://www.prnewswire.co.uk/news-releases/adtec-healthcare-limited-a-leading-cold-plasma-medical-device-manufacturer-spins-out-from-adtec-europe-ltd-301839802.html?tc=eml_cleartime

 


SteriPlas to be presented at the ISDF conference

Image

 

We’re looking forward to supporting Dr Pierides’ presentation at The International Symposium on the Diabetic Foot (ISDF) conference this Friday as he presents the strong benefits of our SteriPlas Cold Plasma medical device for the management of chronic Diabetic Foot Ulcers. His presentation, “DGH experience of using cold argon plasma in treating diabetic foot ulcers and its role in antibiotic stewardship” discusses the outcomes of 37 patients all of whom received once weekly SteriPlas treatment. The SteriPlas is shown to eliminate the use of antibiotics for chronic DFUs inhibited by multi-resistant bacteria. The unique physical mode of action that the SteriPlas delivers to the infection site ensures a total destruction of all antimicrobial resistant bacteria even if they are protected within biofilm.

 

For more information about our clinical evidence and medical device, please contact us at info@adtecplasma.com


Day 2 of EWMA

It's day 2 at EWMA 2023 and we're having a great time meeting with new and existing customers. If you want to learn about the most effective Cold Plasma medical device for woundccare with the most clinical trials, strongest efficacy and no side effects, please visit our booth at no. 116 to see a live demonstration of the SteriPlas in action.

 


Thomas presents at the ISHLT show

A fantastic presentation delivered by Thomas Schlöglhofer yesterday at the ISHLT - International Society for Heart and Lung Transplantation show. We hope you got the chance to see his presentation and the promising results he has achieved managing LVAD infections with our Cold Plasma SteriPlas medical device. If you are interested to learn more about the SteriPlas and the benefits it can bring to your patients, please contact us at info@adtecplasma.com

 


A great start to the ISHLT show

What a fantastic start to the International Society For Heart and Lung Transplantation! We’ve been swamped with your presence and interest. It’s been a pleasure to meet new and old faces and we’ve been excited to share how well our leading Cold Plasma SteriPlas medical device is changing lives in the UK and Europe for LVAD patients.

We look forward to welcoming you to our booth no.416 ready to introduce you to the strong benefits of our Cold Plasma efficacy.


How does the Adtec SteriPlas work so effectively?

Our patented cold plasma therapy utilises a physical mode of action approach delivered from an indirect microwave plasma source. Our cold argon plasma is an electrically charged and ionised gas that consists of charged particles, UV light and reactive oxygen and nitrogen species with the latter created as a by-product. They all work collectively to physically rupture the structure of bacteria even if they are protected within biofilm. Regardless of the type of bacteria, its resistance profile or whether they are Gram-positive or Gram-negative our cold plasma works quickly and effectively to destroy them. This has the leading advantage over conventional therapies such as antibiotics that rely on a chemical mode of action approach.

 

Although antibiotics have been a pivotal part of today’s medicine, they also contribute towards antimicrobial resistance rates particularly because bacteria can develop resistance such as those observed with diabetic foot ulcers that can often lead to amputations as a result.

 

However, as well as being fast-acting and effective, our cold plasma has shown that a primary or secondary resistance is unlikely to be developed due to its physical mode of action.

 


Mr Schlöglhofer to present SteriPlas at the ISHLT

Congratulations to Thomas Schlöglhofer from the Medical University of Vienna for his continued success of using our medical device to treat infections in LVAD patients. He will be presenting at The International Society for Heart and Lung Transplantation (ISHLT) conference in April to deliver the great results he has so far achieved.

 

His presentation, “Cold Atmospheric Plasma Therapy: A Powerful Tool for Treating Driveline Infections in Left Ventricular Assist Device Patients” will be during the “Bugs, Drugs, and Thugs: Fighting Infection in VADs Any Way We Can” Session on Wednesday 19th April between 5:30 PM - 6:30 PM.

 

We hope you will be there too to see him deliver his promising results.

 

For more information on how our medical device is fighting against multi resistant bacteria and biofilm in LVAD patients.



Today at The DGTHT Hermedizin 2023

It was a pleasure to see Dr Rotering’s presentation today at the DGTHT Hermedizin 2023 conference. His presentation on the SteriPlas for the treatment of deep sternal wound infections shows just how effective our Cold Plasma medical device is for the treatment of these chronic and deep wounds infected with biofilm.

 

Not only has the SteriPlas has shown to significantly decrease hospital bed occupancy, but it has shown to reduce mortality rates and prevent the need for expensive treatments by allowing sternal wall stability. The SteriPlas can successfully kill all forms of bacteria, regardless of their resistance profile or if they are protected within biofilm.

 


SteriPlas heals wounds quickly

Did you catch the leading Serbian media newspaper, Večernje Novosti, last week? Our SteriPlas was featured in the article, “Cold plasma heals wounds quickly” composed by Dr Zorić.

Dr Zoric has been using our cold plasma medical device to treat hard-to-heal and stalled wounds infected with biofilm. These problematic wounds have responded very well with our SteriPlas treatment and patients have been healed that were otherwise stalled by conventional therapies.

 

If you are within Serbia and interested to learn more about our medical device, contact our medical distributor Borf Health Care on info@borf.biz for more information.

 


Dr H. Rotering presenting SteriPlas DSWI efficacy at Herzmidizin 2023 conference

 

Dr Heinrich Rotering will be presenting at the Herzmedizin 2023 conference on 14th February 2023. His presentation, “Tissue saving – Plasma based treatment concept for sternal infection including one year follow-up” will show the benefits of our SteriPlas cold plasma medical device for the treatment of deep sternal wound infections.

 

The benefit our cold plasma device has for these chronic wound infections is the ability to give a deep penetration treatment allowing plasma coverage over the wide infected area. As our medical device is the only microwave-powered, argon cold plasma device with a wide 12cm2 treatment size and is contact-free, the overall sessions are quickly completed. The mean wound healing for deep sternal wound infections is 16 days with the SteriPlas.

 

Contact us at info@adtecplasma.com to learn more about the SteriPlas.